Login
Israel-Hamas Conflict
Independence Day
Parade
Social Media
Motorsports
Natural Disasters
Cricket
Artificial Intelligence
Drones
Taxes
Donald Trump
Floods
Cryptocurrency
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

A Look Back to ASCO 2025: Industry Comments From iOnctura and Asgard Therapeutics

Summary by Pharmaphorum
Here, Michelle Tsai – chief operating officer at iOnctura – and Shane Olwill – chief development officer at Asgard Therapeutics – share their views on the broader cancer care landscape and ponder what’s hyped, what’s not being duly appreciated, and what might be coming next.

2 Articles

All
Left
Center
1
Right
PharmaphorumPharmaphorum
Center

A look back to ASCO 2025: Industry comments from iOnctura and Asgard Therapeutics

Here, Michelle Tsai – chief operating officer at iOnctura – and Shane Olwill – chief development officer at Asgard Therapeutics – share their views on the broader cancer care landscape and ponder what’s hyped, what’s not being duly appreciated, and what might be coming next.

Read Full Article
targetedonc.comtargetedonc.com

The Evolving Role of ctDNA in Colorectal Cancer: Updates from ASCO 2025

Anita Turk, MD, discusses abstracts from ASCO 2025 highlight the evolving role of ctDNA in the management of colorectal cancer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

targetedonc.com broke the news in on Thursday, July 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Maryland icon

Maryland

News
For You
SearchBlindspotLocal